Treasury Wine profit drops 50% for 2013

Cost of sales seems to be the main culprit behind the squeeze.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Treasury Wine Estates (ASX: TWE) reported full-year 2013 earnings today, edging up its top line but drastically dropping its bottom line. Revenue for the year clocked in at $1.73 billion, 2.8% above 2012's $1.68 billion in sales.

The minor improvement in sales points to potential growth, but the Treasury Wine's bottom line profits plummeted. While EBITS stayed steady at $209 million, profitable attributable to shareholders dropped over 50% to $42.3 million.

Cost of sales seems to be the main culprit behind the squeeze, with gross margins dropping 10 percentage points from 35% in 2012 to 25% this year. For investors, all this whittles down to adjusted EPS of $0.065 for 2013, compared to 2012's $0.138.

Looking ahead, CEO David Dearie noted, "While fiscal 2013 was a challenging year for TWE, the fundamentals of the global wine industry have not changed. The supply and demand cycle is moving towards balance and global consumer demand for premium wine brands continues to grow. We remain focussed on investing in and supporting our portfolio of iconic brands, with planned brand building investment expected to increase significantly in fiscal 2014 as we continue to drive higher volume and sales growth."

For 2014, the company will take a $30 million hit due to excessive U.S. inventory levels, and expects EBITS to register in the range of $230 million to $250 million.

As Treasury Wine recovers from a tough year, why not enjoy some sustainable profits with your Pinot Gris? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Justin Loiseau has no position in any stocks mentioned in this article. You can follow him on Twitter @TMFJLo.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »